135 related articles for article (PubMed ID: 20590345)
21. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; Ruaño G
Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
Shah RR
Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
[TBL] [Abstract][Full Text] [Related]
24. [Implication of genetic polymorphism on neuropathic pain].
Iseki M; Sato-Takeda M
Masui; 2009 Sep; 58(9):1112-21. PubMed ID: 19764434
[TBL] [Abstract][Full Text] [Related]
25. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
[TBL] [Abstract][Full Text] [Related]
26. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
Bell GC; Donovan KA; McLeod HL
Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969
[TBL] [Abstract][Full Text] [Related]
27. Personalized therapy in pain management: where do we stand?
Stamer UM; Zhang L; Stüber F
Pharmacogenomics; 2010 Jun; 11(6):843-64. PubMed ID: 20504256
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of opioid response.
Somogyi AA; Coller JK; Barratt DT
Clin Pharmacol Ther; 2015 Feb; 97(2):125-7. PubMed ID: 25670515
[TBL] [Abstract][Full Text] [Related]
30. Pain management of musculoskeletal injuries in children: current state and future directions.
Ali S; Drendel AL; Kircher J; Beno S
Pediatr Emerg Care; 2010 Jul; 26(7):518-24; quiz 525-8. PubMed ID: 20622635
[TBL] [Abstract][Full Text] [Related]
31. Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
[TBL] [Abstract][Full Text] [Related]
32. Current evidence for a genetic modulation of the response to analgesics.
Lötsch J; Geisslinger G
Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
[No Abstract] [Full Text] [Related]
33. Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Ruan X; Bumgarner GW; Labrie-Brown C; Kaye AD
Clin J Pain; 2016 Dec; 32(12):1105-1106. PubMed ID: 26889610
[No Abstract] [Full Text] [Related]
34. CYP2D6 in the metabolism of opioids for mild to moderate pain.
Leppert W
Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
[TBL] [Abstract][Full Text] [Related]
35. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management.
Flores CM; Mogil JS
Pharmacogenomics; 2001 Aug; 2(3):177-94. PubMed ID: 11535108
[TBL] [Abstract][Full Text] [Related]
36. Codeine: Time to Say "No".
Tobias JD; Green TP; Coté CJ; ;
Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27647717
[TBL] [Abstract][Full Text] [Related]
37. The pharmacogenetics of analgesia.
Stamer UM; Stüber F
Expert Opin Pharmacother; 2007 Oct; 8(14):2235-45. PubMed ID: 17927480
[TBL] [Abstract][Full Text] [Related]
38. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
39. Codeine-related deaths: The role of pharmacogenetics and drug interactions.
Lam J; Woodall KL; Solbeck P; Ross CJ; Carleton BC; Hayden MR; Koren G; Madadi P
Forensic Sci Int; 2014 Jun; 239():50-6. PubMed ID: 24747667
[TBL] [Abstract][Full Text] [Related]
40. Genetics and variability in opioid response.
Stamer UM; Bayerer B; Stüber F
Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
